A detailed history of Virtus ETF Advisers LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 8,925 shares of PTCT stock, worth $350,127. This represents 0.16% of its overall portfolio holdings.

Number of Shares
8,925
Previous 8,925 -0.0%
Holding current value
$350,127
Previous $272,000 21.69%
% of portfolio
0.16%
Previous 0.14%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$24.69 - $40.12 $120,487 - $195,785
-4,880 Reduced 35.35%
8,925 $272,000
Q1 2024

May 15, 2024

BUY
$24.15 - $31.95 $47,961 - $63,452
1,986 Added 16.8%
13,805 $401,000
Q4 2023

Feb 15, 2024

BUY
$18.07 - $29.37 $85,724 - $139,331
4,744 Added 67.05%
11,819 $325,000
Q3 2023

Nov 07, 2023

SELL
$22.41 - $41.99 $20,482 - $38,378
-914 Reduced 11.44%
7,075 $158,000
Q2 2023

Aug 14, 2023

BUY
$40.4 - $59.1 $8,282 - $12,115
205 Added 2.63%
7,989 $324,000
Q1 2023

May 15, 2023

BUY
$38.16 - $48.86 $5,189 - $6,644
136 Added 1.78%
7,784 $377,000
Q4 2022

Feb 14, 2023

SELL
$33.53 - $54.79 $51,267 - $83,773
-1,529 Reduced 16.66%
7,648 $291,000
Q3 2022

Nov 14, 2022

BUY
$41.85 - $53.85 $5,607 - $7,215
134 Added 1.48%
9,177 $461,000
Q2 2022

Aug 12, 2022

SELL
$25.6 - $45.23 $25,369 - $44,822
-991 Reduced 9.88%
9,043 $362,000
Q4 2021

Feb 14, 2022

SELL
$35.36 - $41.86 $13,507 - $15,990
-382 Reduced 3.67%
10,034 $400,000
Q3 2021

Nov 15, 2021

SELL
$37.01 - $44.74 $35,233 - $42,592
-952 Reduced 8.37%
10,416 $388,000
Q2 2021

Aug 10, 2021

BUY
$37.95 - $49.37 $71,801 - $93,408
1,892 Added 19.97%
11,368 $481,000
Q1 2021

May 17, 2021

BUY
$46.8 - $68.92 $11,980 - $17,643
256 Added 2.78%
9,476 $449,000
Q4 2020

Feb 12, 2021

SELL
$47.96 - $67.64 $126,758 - $178,772
-2,643 Reduced 22.28%
9,220 $563,000
Q3 2020

Nov 13, 2020

BUY
$45.41 - $57.07 $45,364 - $57,012
999 Added 9.2%
11,863 $555,000
Q2 2020

Aug 05, 2020

SELL
$42.56 - $54.98 $56,732 - $73,288
-1,333 Reduced 10.93%
10,864 $551,000
Q1 2020

May 14, 2020

SELL
$32.37 - $59.36 $33,308 - $61,081
-1,029 Reduced 7.78%
12,197 $544,000
Q4 2019

Feb 13, 2020

BUY
$32.22 - $50.07 $222,897 - $346,384
6,918 Added 109.67%
13,226 $635,000
Q3 2019

Nov 12, 2019

SELL
$33.82 - $48.17 $11,904 - $16,955
-352 Reduced 5.29%
6,308 $213,000
Q2 2019

Aug 13, 2019

SELL
$35.42 - $45.0 $45,585 - $57,915
-1,287 Reduced 16.19%
6,660 $300,000
Q1 2019

May 14, 2019

SELL
$28.09 - $39.49 $19,691 - $27,682
-701 Reduced 8.11%
7,947 $299,000
Q4 2018

Feb 05, 2019

SELL
$29.83 - $46.51 $109,714 - $171,063
-3,678 Reduced 29.84%
8,648 $297,000
Q3 2018

Nov 14, 2018

SELL
$33.9 - $47.77 $298,794 - $421,044
-8,814 Reduced 41.69%
12,326 $579,000
Q2 2018

Aug 10, 2018

SELL
$25.7 - $47.88 $662,468 - $1.23 Million
-25,777 Reduced 54.94%
21,140 $713,000
Q1 2018

May 14, 2018

BUY
$17.46 - $32.59 $439,380 - $820,127
25,165 Added 115.69%
46,917 $1.27 Million
Q4 2017

Feb 14, 2018

BUY
$15.14 - $20.89 $32,399 - $44,704
2,140 Added 10.91%
21,752 $363,000
Q3 2017

Nov 14, 2017

BUY
$16.81 - $21.61 $30,157 - $38,768
1,794 Added 10.07%
19,612 $392,000
Q2 2017

Aug 14, 2017

BUY
N/A
17,818
17,818 $327,000

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $2.81B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Virtus ETF Advisers LLC Portfolio

Follow Virtus ETF Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.